These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37482615)

  • 1. Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis.
    Lloyd GM; Long B; Quintin S; Sorrentino ZA; Gorion KM; Bell BM; Carrillo D; Sullivan P; Borchelt D; Giasson BI
    Acta Neuropathol Commun; 2023 Jul; 11(1):119. PubMed ID: 37482615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different isoforms of apoE on aggregation of the α-synuclein protein implicated in Parkinson's disease.
    Emamzadeh FN; Aojula H; McHugh PC; Allsop D
    Neurosci Lett; 2016 Apr; 618():146-151. PubMed ID: 26921451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncation or proteolysis of α-synuclein in Parkinsonism.
    Suthar SK; Lee SY
    Ageing Res Rev; 2023 Sep; 90():101978. PubMed ID: 37286088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.
    Zhao N; Attrebi ON; Ren Y; Qiao W; Sonustun B; Martens YA; Meneses AD; Li F; Shue F; Zheng J; Van Ingelgom AJ; Davis MD; Kurti A; Knight JA; Linares C; Chen Y; Delenclos M; Liu CC; Fryer JD; Asmann YW; McLean PJ; Dickson DW; Ross OA; Bu G
    Sci Transl Med; 2020 Feb; 12(529):. PubMed ID: 32024798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids.
    Zhao J; Lu W; Ren Y; Fu Y; Martens YA; Shue F; Davis MD; Wang X; Chen K; Li F; Liu CC; Graff-Radford NR; Wszolek ZK; Younkin SG; Brafman DA; Ertekin-Taner N; Asmann YW; Dickson DW; Xu Z; Pan M; Han X; Kanekiyo T; Bu G
    Acta Neuropathol; 2021 Nov; 142(5):807-825. PubMed ID: 34453582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
    Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
    Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
    Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
    Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Isoforms and Carboxyl-Terminal Truncations on the Capacity of Apolipoprotein E To Associate with and Activate Phospholipid Transfer Protein.
    Dafnis I; Metso J; Zannis VI; Jauhiainen M; Chroni A
    Biochemistry; 2015 Sep; 54(38):5856-66. PubMed ID: 26337529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Chronic Cadmium Exposure on Brain and Liver Transporters and Drug-Metabolizing Enzymes in Male and Female Mice Genetically Predisposed to Alzheimer's Disease.
    Wang H; Zhang L; Xia Z; Cui JY
    Drug Metab Dispos; 2022 Oct; 50(10):1414-1428. PubMed ID: 35878927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
    Muntané G; Ferrer I; Martinez-Vicente M
    Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological biochemistry of alpha-synucleinopathy.
    Iwatsubo T
    Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E.
    Nguyen D; Dhanasekaran P; Nickel M; Mizuguchi C; Watanabe M; Saito H; Phillips MC; Lund-Katz S
    Biochemistry; 2014 Jun; 53(24):4025-33. PubMed ID: 24871385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.